These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 14268)

  • 1. [Bacteriological evaluation of clindamycin-2-phosphate (author's transl)].
    Ono H; Ohtsuki M; Nakazawa S
    Jpn J Antibiot; 1977 Jan; 30(1):1-6. PubMed ID: 14268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bacteriological study on clindamycin-2-palmitate (author's transl)].
    Ono H; Otsuki M; Nakazawa S
    Jpn J Antibiot; 1973 Aug; 26(4):321-4. PubMed ID: 4582578
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical experience with clindamycin-2-phosphate for injection in dermatological field (author's transl)].
    Matsumoto S; Kaneko O; Makino N; Miwa K; Takahashi H
    Jpn J Antibiot; 1977 Jan; 30(1):111-3. PubMed ID: 839634
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of clindamycin-2-phosphate in ophthalmology (author's transl)].
    Tokuda H; Hatano H; Kayaba T
    Jpn J Antibiot; 1977 Jan; 30(1):107-10. PubMed ID: 14269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of subacute bacterial endocarditis treated with clindamycin-2-phosphate (author's transl)].
    Mashimo K; Kunii O; Fukaya K; Kimura M; Komatsu T
    Jpn J Antibiot; 1977 Jan; 30(1):23-6. PubMed ID: 839639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro pharmacokinetic/pharmacodynamic activity of NXL103 versus clindamycin and linezolid against clinical Staphylococcus aureus and Streptococcus pyogenes isolates.
    Vidaillac C; Parra-Ruiz J; Winterfield P; Rybak MJ
    Int J Antimicrob Agents; 2011 Oct; 38(4):301-6. PubMed ID: 21764263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clindamycin-2-phosphate in the field of dermatology (author's transl)].
    Arata J; Yamamoto Y; Suwaki M; Nohara N
    Jpn J Antibiot; 1977 Jan; 30(1):114-6. PubMed ID: 839635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical evaluation of clindamycin-2-phosphate for injection in acute respiratory infection of children (author's transl)].
    Nakazawa S; Sato H; Niino K; Fujii N; Kojima S
    Jpn J Antibiot; 1977 Jan; 30(1):59-68. PubMed ID: 839645
    [No Abstract]   [Full Text] [Related]  

  • 9. Clindamycin in infective endocarditis.
    Cherubin CE; Nair SR
    JAMA; 1978 Feb; 239(7):626-7. PubMed ID: 563932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study of clindamycin-2-palmitate treatment in pediatric infections (author's transl)].
    Kato H; Iwai N
    Jpn J Antibiot; 1973 Aug; 26(4):356-60. PubMed ID: 4147526
    [No Abstract]   [Full Text] [Related]  

  • 11. Clindamycin as an anti-staphylococcal agent--indications and limitations.
    Hedström SA
    Scand J Infect Dis Suppl; 1984; 43():62-6. PubMed ID: 6598522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Basic and clinical studies on clindamycin for intravenous injection (author's transl)].
    Imaoka M; Uzuka Y; Noguchi Y; Watanabe K; Matsumoto K
    Jpn J Antibiot; 1977 Jan; 30(1):51-8. PubMed ID: 839644
    [No Abstract]   [Full Text] [Related]  

  • 13. Auranofin efficacy against MDR Streptococcus pneumoniae and Staphylococcus aureus infections.
    Aguinagalde L; Díez-Martínez R; Yuste J; Royo I; Gil C; Lasa Í; Martín-Fontecha M; Marín-Ramos NI; Ardanuy C; Liñares J; García P; García E; Sánchez-Puelles JM
    J Antimicrob Chemother; 2015 Sep; 70(9):2608-17. PubMed ID: 26142477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clindamycin-2-phosphate and surgical infections (author's transl)].
    Ishibiki H; Murayama N; Hosoda Y; Katsumoto K; Takami H
    Jpn J Antibiot; 1977 Jan; 30(1):69-75. PubMed ID: 320362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antimicrobial activity of clindamycin analogues: pirlimycin, 1,2 a potent antibacterial agent.
    Birkenmeyer RD; Kroll SJ; Lewis C; Stern KF; Zurenko GE
    J Med Chem; 1984 Feb; 27(2):216-23. PubMed ID: 6363698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential clindamycin resistance in clindamycin-susceptible, erythromycin-resistant Staphylococcus aureus: report of a clinical failure.
    Levin TP; Suh B; Axelrod P; Truant AL; Fekete T
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1222-4. PubMed ID: 15728934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Laboratory and clinical evaluation of clindamycin-2-palmitate in pediatric field (author's transl)].
    Fujii R; Konno M; Ubukata K; Sakuma A
    Jpn J Antibiot; 1973 Dec; 26(6):545-61. PubMed ID: 4150085
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical evaluation of clindamycin-2-phosphate in infectious diseases (author's transl)].
    Fujimori I; Shimada S; Koizumi H
    Jpn J Antibiot; 1977 Jan; 30(1):39-41. PubMed ID: 320361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bacteriological studies on fosfomycin. Antibacterial activity in vitro and in vivo (author's transl)].
    Miyauchi K; Yoshida T; Kasai T; Saito T; Hirano H
    Jpn J Antibiot; 1975 Jun; 28(3):320-30. PubMed ID: 807758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Environmental gram-positive mastitis treatment: in vitro sensitivity and bacteriologic cure.
    Cattell MB; Dinsmore RP; Belschner AP; Carmen J; Goodell G
    J Dairy Sci; 2001 Sep; 84(9):2036-43. PubMed ID: 11573783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.